ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 113 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,756,000 | +166.9% | 100,000 | +274.5% | 0.21% | -24.7% |
| Q4 2017 | $658,000 | -68.7% | 26,700 | -67.2% | 0.28% | -64.9% |
| Q3 2017 | $2,104,000 | +69.7% | 81,500 | +78.2% | 0.80% | +51.9% |
| Q2 2017 | $1,240,000 | -9.1% | 45,740 | 0.0% | 0.52% | -4.4% |
| Q1 2017 | $1,364,000 | -60.3% | 45,740 | -63.9% | 0.55% | -67.3% |
| Q4 2016 | $3,439,000 | +402.8% | 126,700 | +374.5% | 1.67% | +594.6% |
| Q3 2016 | $684,000 | -38.3% | 26,700 | -55.5% | 0.24% | -86.2% |
| Q2 2016 | $1,108,000 | – | 60,000 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |